123 related articles for article (PubMed ID: 35154531)
1. TERT rs2853669 as a predictor for overall survival in patients with acute myeloid leukaemia.
Tripon F; Bănescu C; Trifa AP; Crauciuc AG; Moldovan VG; Boglis A; Benedek I; Demian S; Duicu C; Iancu M
Arch Med Sci; 2022; 18(1):103-111. PubMed ID: 35154531
[TBL] [Abstract][Full Text] [Related]
2. Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.
Mosrati MA; Willander K; Falk IJ; Hermanson M; Höglund M; Stockelberg D; Wei Y; Lotfi K; Söderkvist P
Oncotarget; 2015 Sep; 6(28):25109-20. PubMed ID: 26298771
[TBL] [Abstract][Full Text] [Related]
3. DNMT3A (R882) mutation features and prognostic effect in acute myeloid leukemia in Coexistent with NPM1 and FLT3 mutations.
Kumar D; Mehta A; Panigrahi MK; Nath S; Saikia KK
Hematol Oncol Stem Cell Ther; 2018 Jun; 11(2):82-89. PubMed ID: 29079128
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia patient with
Huang Y; Hu J; Lu T; Luo Y; Shi J; Wu W; Han X; Zheng W; He J; Cai Z; Wei G; Huang H; Sun J
Cancer Manag Res; 2019; 11():4129-4142. PubMed ID: 31190985
[No Abstract] [Full Text] [Related]
5. TERT genetic variability and telomere length as factors affecting survival and risk in acute myeloid leukaemia.
Dratwa M; Wysoczańska B; Butrym A; Łacina P; Mazur G; Bogunia-Kubik K
Sci Rep; 2021 Dec; 11(1):23301. PubMed ID: 34857839
[TBL] [Abstract][Full Text] [Related]
6. Cytokine rs361525, rs1800750, rs1800629, rs1800896, rs1800872, rs1800795, rs1800470, and rs2430561 SNPs in relation with prognostic factors in acute myeloid leukemia.
Bănescu C; Tripon F; Trifa AP; Crauciuc AG; Moldovan VG; Bogliş A; Benedek I; Dima D; Cândea M; Duicu C; Iancu M
Cancer Med; 2019 Sep; 8(12):5492-5506. PubMed ID: 31373163
[TBL] [Abstract][Full Text] [Related]
7. Association between
Tong Y; Xiang Y; Li B; Bao S; Zhou Y; Yuan W; Ling Y; Hao D; Zhu H; Sun Z
Cancer Cell Int; 2020; 20():313. PubMed ID: 32694935
[TBL] [Abstract][Full Text] [Related]
8. Association of TLR4 Rs4986791 Polymorphism and TLR9 Haplotypes with Acute Myeloid Leukemia Susceptibility: A Case-Control Study of Adult Patients.
Banescu C; Tripon F; Bojan AS; Trifa AP; Muntean C; Crauciuc GA; Boglis A; Candea M; Lazar E; Jimbu L; Iancu M
J Pers Med; 2022 Mar; 12(3):. PubMed ID: 35330409
[TBL] [Abstract][Full Text] [Related]
9. DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation.
Ahn JS; Kim HJ; Kim YK; Lee SS; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD
Biol Blood Marrow Transplant; 2016 Jan; 22(1):61-70. PubMed ID: 26234722
[TBL] [Abstract][Full Text] [Related]
10. [Effect of FLT3-ITD with DNMT3A R882 double-mutation on the prognosis of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation].
Tang SH; Lu Y; Zhang PS; Liu XH; Du XH; Chen D; Sha KY; Li SY; Cao JJ; Chen LG; Zhuang XX; Pei RZ; Tang XW
Zhonghua Xue Ye Xue Za Zhi; 2018 Jul; 39(7):552-557. PubMed ID: 30122013
[No Abstract] [Full Text] [Related]
11. Clinical implications of
Tan M; Ng IKS; Chen Z; Ban K; Ng C; Chiu L; Seah E; Lin M; Tai BC; Yan B; Ng CH; Chng WJ
J Clin Pathol; 2017 Aug; 70(8):669-676. PubMed ID: 28100593
[TBL] [Abstract][Full Text] [Related]
12. FLT3-ITD Compared with DNMT3A R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.
Ardestani MT; Kazemi A; Chahardouli B; Mohammadi S; Nikbakht M; Rostami S; Jalili M; Vaezi M; Alimoghaddam K; Ghavamzadeh A
Turk J Haematol; 2018 Aug; 35(3):158-167. PubMed ID: 29786546
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of mutant NPM1 and CEBPA in patients with acute myeloid leukaemia - preliminary report.
Helbig G; Wozniczka K; Wieclawek A; Soja A; Bartkowska-Chrobok A; Kyrcz-Krzemien S
Contemp Oncol (Pozn); 2014; 18(4):241-5. PubMed ID: 25258581
[TBL] [Abstract][Full Text] [Related]
14. TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas.
Nencha U; Rahimian A; Giry M; Sechi A; Mokhtari K; Polivka M; Schmitt Y; Di Stefano AL; Alentorn A; Labussière M; Sanson M
J Neurooncol; 2016 Feb; 126(3):441-6. PubMed ID: 26608520
[TBL] [Abstract][Full Text] [Related]
15. Association between functional TERT promoter polymorphism rs2853669 and cervical cancer risk in South Indian women.
Vinothkumar V; Arun K; Arunkumar G; Revathidevi S; Ramani R; Bhaskar LVKS; Murugan AK; Munirajan AK
Mol Clin Oncol; 2020 May; 12(5):485-494. PubMed ID: 32257207
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterisation of
Kloppers JF; de Kock A; Cronjé J; van Marle AC
Afr J Lab Med; 2021; 10(1):1363. PubMed ID: 34230878
[TBL] [Abstract][Full Text] [Related]
17. Clinical Effect of Combined Mutations in DNMT3A, FLT3-ITD, and NPM1 Among Egyptian Acute Myeloid Leukemia Patients.
El Gammal MM; Ebid GT; Madney YM; Abo-Elazm OM; Kelany AK; Torra OS; Radich JP
Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e281-e290. PubMed ID: 30926392
[TBL] [Abstract][Full Text] [Related]
18. The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
Batista R; Cruvinel-Carloni A; Vinagre J; Peixoto J; Catarino TA; Campanella NC; Menezes W; Becker AP; de Almeida GC; Matsushita MM; Clara C; Neder L; Viana-Pereira M; Honavar M; Castro L; Lopes JM; Carvalho B; Vaz RM; Máximo V; Soares P; Sobrinho-Simões M; Reis RM; Lima J
Int J Cancer; 2016 Jul; 139(2):414-23. PubMed ID: 26914704
[TBL] [Abstract][Full Text] [Related]
19. Clinico-Haematologic association and prognostic relevance of NPM1 and FLT3-ITD mutations in acute Myeloid Leukaemia.
Mahmood R; Altaf C; Malik HS; Khan SA
Pak J Med Sci; 2019; 35(1):23-28. PubMed ID: 30881390
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of de novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations.
Loghavi S; Zuo Z; Ravandi F; Kantarjian HM; Bueso-Ramos C; Zhang L; Singh RR; Patel KP; Medeiros LJ; Stingo F; Routbort M; Cortes J; Luthra R; Khoury JD
J Hematol Oncol; 2014 Oct; 7():74. PubMed ID: 25281355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
